AC Share Price
NASDAQ: ACIU | HealthcareAC Stock Performance
AC Share Price Today
As of 21 November 2026, AC Immune SA's share price is $1.95. The stock opened at $2.12, compared to its previous close of $2.13. During today's trading session, AC Immune SA's share price traded between $1.93 and $2.15, with an average price of $2.04. Over the past 52 weeks, the stock has recorded a high of $3.90 and a low of $1.93. In terms of performance, AC Immune SA's share price has declined by 26.55% over the last six months and is down 34.34% on a year-on-year basis.
AC Share Price Chart
AC Annual Profit & Loss
All figures in USD
AC Balance Sheet
All figures in USD Million
AC Cash Flow
All figures in USD Million
About AC
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
AC Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.20 | $1.93 | -13.84% |
Oct 2026 | $2.65 | $2.24 | -14.83% |
Sep 2026 | $2.64 | $2.63 | -2.23% |
Aug 2026 | $2.20 | $2.69 | +22.83% |
Jul 2026 | $2.31 | $2.19 | -8.18% |
Jun 2026 | $2.60 | $2.38 | -10.17% |
May 2026 | $3.06 | $2.65 | -12.66% |
Apr 2026 | $2.89 | $3.04 | +10.55% |
Mar 2026 | $2.83 | $2.75 | -6.46% |
Feb 2026 | $3.22 | $2.94 | -7.40% |
Jan 2026 | $3.19 | $3.17 | +1.28% |
Dec 2025 | $2.95 | $3.13 | +5.56% |